Alex Durand Nka

Viral suppression in adults, adolescents and children receiving antiretroviral therapy in Cameroon: adolescents at high risk of virological failure in the era of “test and treat”

Joseph Fokam, Samuel Martin Sosso, Yagaï Bouba et al. · AIDS Research and Therapy · 2019 · 63 citations · Full text

Public Health, Infectious Diseases, Pediatrics +17

Evaluation of HIV-1 capsid genetic variability and lenacapavir (GS-6207) drug resistance-associated mutations according to viral clades among drug-naive individuals

Alex Durand Nka, Yagaï Bouba, Georges Této et al. · Journal of Antimicrobial Chemotherapy · 2022 · 27 citations

Life Sciences, Molecular Genetics, Pharmacology +17

Thrombocytopenia according to antiretroviral drug combinations, viremia and CD4 lymphocytes among HIV-infected patients in Cameroon: a snapshot from the City of Yaoundé

Alex Durand Nka, Samuel Martin Sosso, Joseph Fokam et al. · BMC Research Notes · 2019 · 25 citations · Full text

Medicine, Hematology, Infectious Diseases +11

Baseline integrase drug resistance mutations and conserved regions across HIV-1 clades in Cameroon: implications for transition to dolutegravir in resource-limited settings

Ezéchiel Ngoufack Jagni Semengue, Daniele Armenia, Seth Inzaule et al. · Journal of Antimicrobial Chemotherapy · 2021 · 25 citations · Full text

Life Sciences, Microbiology, Pharmacotherapy +17

Viral suppression in the era of transition to dolutegravir-based therapy in Cameroon: Children at high risk of virological failure due to the lowly transition in pediatrics

Joseph Fokam, Alex Durand Nka, Flore Yollande Mamgue Dzukam et al. · Medicine · 2023 · 25 citations · Full text

Public Health, Infectious Diseases, Pediatrics +17